Smartleaf Asset Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Smartleaf Asset Management’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-777	Closed	-$7.37K	–	3044
2024 Q4	$7.37K	Buy	777 +544	+233%	+$2.84K	﹤0.01%	2111
2024 Q3	$675	Buy	+233	New	+$721	﹤0.01%	2741

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Smartleaf Asset Management's PSTX Position: Q1 2025 in Review

Smartleaf Asset Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 777 shares — an estimated $7.37K sold.

Smartleaf Asset Management first reported a position in PSTX in Q3 2024 and held it in 2 quarters. The position peaked at $7.37K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Smartleaf Asset Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Smartleaf Asset Management sold 777 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $7.37K.
Smartleaf Asset Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
Smartleaf Asset Management's Poseida Therapeutics, Inc. Common Stock position peaked at $7.37K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Smartleaf Asset Management's 13F filing for Q1 2025, filed 14 May 2025.